Latest Period
n/a
Security Snapshot
Zivo Bioscience - Common Stock, par value $.001 per share (ZIVO) Institutional Ownership
CUSIP: 98978N101
13F Institutional Holders and Ownership History from Q4 2014 to Q4 2023
Institutions Reporting
Shares (Excl. Options)
Price
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.
- Type / Class
- Equity / Common Stock, par value $.001 per share
- Symbol
- ZIVO on OTC
- Shares outstanding
- 3,908,612
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- ZIVO - Zivo Bioscience - Common Stock, par value $.001 per share is tracked under CUSIP 98978N101.
- Latest finished 13F holder period is not available.
- 2 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 2 to 0 between Q3 2023 and Q4 2023.
- Reported value moved from $44,070 to $0.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Schedule 13D/G
Open SEC Evidence
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
Investment Quick Answers
What is CUSIP 98978N101?
CUSIP 98978N101 identifies ZIVO - Zivo Bioscience - Common Stock, par value $.001 per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 98978N101:
Significant Owners of Zivo Bioscience - Common Stock, par value $.001 per share (ZIVO) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| STROME MARK E | 12% | 472,942 | Mark E. Strome | 31 Dec 2025 | ||||
| STROME MEZZANINE FUND, LP | 12% | $53,142 | 442,854 | Mark E. Strome | 26 Dec 2024 |
Institutional Holders of Zivo Bioscience - Common Stock, par value $.001 per share (ZIVO) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2023 Q4 | 0 | $0 | -$28,470 | 0 | |
| 2023 Q3 | 33,900 | $44,070 | -$455 | $1.30 | 2 |
| 2023 Q2 | 34,250 | $82,885 | -$11,570 | $2.42 | 2 |
| 2023 Q1 | 12,000 | $36,960 | $3.08 | 1 | |
| 2022 Q4 | 38,166 | $95,415 | -$129,000 | $2.50 | 2 |
| 2022 Q3 | 82,936 | $232,000 | $2.80 | 2 | |
| 2022 Q2 | 82,936 | $326,000 | $3.93 | 2 | |
| 2022 Q1 | 82,936 | $322,000 | $3.89 | 2 | |
| 2021 Q4 | 82,936 | $238,000 | $2.87 | 2 | |
| 2021 Q2 | 0 | $0 | -$55,240 | 0 | |
| 2021 Q1 | 432,553 | $55,240 | $0.13 | 3 | |
| 2020 Q4 | 432,553 | $65,000 | $0.15 | 3 | |
| 2020 Q3 | 432,553 | $50,464 | $0.12 | 3 | |
| 2020 Q2 | 432,553 | $47,672 | $0.11 | 3 | |
| 2020 Q1 | 472,553 | $55,352 | $0.12 | 4 | |
| 2019 Q4 | 392,553 | $65,200 | $0.17 | 3 | |
| 2019 Q3 | 432,553 | $30,608 | $0.07 | 3 | |
| 2019 Q2 | 432,553 | $44,104 | $0.10 | 3 | |
| 2019 Q1 | 432,553 | $60,200 | +$30,887 | $0.14 | 3 |
| 2018 Q4 | 211,020 | $27,400 | +$7,000 | $0.13 | 3 |
| 2018 Q3 | 160,000 | $25,800 | $0.16 | 2 | |
| 2018 Q2 | 160,000 | $27,600 | $0.17 | 2 | |
| 2018 Q1 | 160,000 | $15,840 | $0.10 | 2 | |
| 2017 Q4 | 80,000 | $8,000 | -$2,000 | $0.10 | 1 |
| 2017 Q3 | 106,000 | $9,000 | $0.08 | 2 | |
| 2017 Q2 | 106,000 | $7,000 | $0.07 | 2 | |
| 2017 Q1 | 106,000 | $9,000 | $0.08 | 2 | |
| 2016 Q4 | 106,000 | $10,000 | $0.09 | 2 | |
| 2016 Q3 | 106,000 | $5,000 | +$1,000 | $0.04 | 2 |
| 2016 Q2 | 80,000 | $5,000 | $0.06 | 1 | |
| 2016 Q1 | 80,000 | $6,000 | $0.08 | 1 | |
| 2015 Q4 | 80,000 | $5,000 | $0.06 | 1 | |
| 2015 Q3 | 105,000 | $8,000 | $0.08 | 2 | |
| 2015 Q2 | 105,000 | $13,000 | +$10,000 | $0.12 | 2 |
| 2015 Q1 | 25,000 | $2,000 | $0.08 | 1 | |
| 2014 Q4 | 25,000 | $2,000 | +$2,000 | $0.08 | 1 |